DNCA Invest Beyond Semperosa NRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31/10/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 11,2 | 20,6 | -18,4 | 16,8 | 3,3 | |
+/-Cat | 2,7 | -3,9 | 2,1 | 0,7 | -0,1 | |
+/-Idx | - | - | - | 0,6 | -4,1 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Benchmark: Morningstar Dev Europe Grt ... |
Kerngegevens | ||
Koers 19/11/2024 | EUR 163,56 | |
Rendement 1 Dag | -0,21% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
ISIN | LU1907595471 | |
Grootte Fonds (Mil) 19/11/2024 | EUR 461,31 | |
Grootte Fondsklasse (Mil) 19/11/2024 | EUR 24,74 | |
Aankoopkosten (Max) | 2,00% | |
Lopende Kosten Factor 05/08/2024 | 1,18% | |
Gesloten voor nieuwe beleggers | nee |
Beleggingsdoelstelling: DNCA Invest Beyond Semperosa N |
The Sub-Fund seeks to outperform the following index denominated in Euro: Euro Stoxx NR (Bloomberg ticker: SXXT Index) calculated with dividends net of withholding taxes reinvested, over the recommended investment term. Investors’ attention is drawn to the fact that the management style is discretionary and integrates environmental, social / societal and governance (ESG) criteria. The Sub-Fund’s philosophy is particularly to focus on companies that have a strong social and/or environmental impact. This impact is evaluated through their exposure (in terms of turnover, R&D expenses or capex) via the proprietary model of the Management Company. The impacts are based on five long-term transitions: economic transition, life style transition, medical transition, demographic transition and energy transition. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Matthieu Belondrade 28/07/2022 | ||
Léa Dunand-Châtellet 17/12/2018 | ||
Click here to see others | ||
Oprichtingsdatum 17/12/2018 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
EURO STOXX NR EUR | Morningstar Dev Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? DNCA Invest Beyond Semperosa N | 31/10/2024 |
|
|
Top 5 posities | Sector | % |
Iberdrola SA | Nutsbedrijven | 5,76 |
ASML Holding NV | Technologie | 5,68 |
Novo Nordisk AS Class B | Gezondheidszorg | 4,12 |
AstraZeneca PLC | Gezondheidszorg | 4,02 |
Air Liquide SA | Grondstoffen | 3,81 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
DNCA Invest Beyond Semperosa N |